通过血液学科的跨学科干预来优化抗真菌的使用.
Maria Alejandra Caro Flautero1,2,3, Maria Camila Rubio2, Edgar Fabián Manrique-Hernández2
1Department of Immunology, Microbiology and Parasitology, Faculty of Medicine and Nursing, University of the Basque Country (UPV/EHU), Bizkaia Campus, 48940 Leioa, Spain.
Journal of fungi (Basel, Switzerland)
|February 26, 2026
概括
哥伦比亚的一项抗真菌管理计划优化了血液病患者的抗真菌使用. 该干预措施将处方转变为预防,减少了广泛的药物使用,并且在中等收入环境中被证明是安全和可行的.
科学领域:
- 传染性疾病 传染性疾病
- 血液学 血液学 血液学
- 药理学 药理学是指药理学的学科.
背景情况:
- 侵入性真菌感染对患有血液性恶性瘤的免疫受损患者构成风险.
- 哥伦比亚的挑战包括有限的诊断,多样化的处方和抗真菌耐药性.
- 在这种患者群体中,优化抗真菌使用至关重要.
研究的目的:
- 在医院的血液病学部门评估跨学科的抗真菌管理干预措施.
- 评估管理对处方模式,消费和患者结果的影响.
- 确定中等收入国家的此类计划的可行性和安全性.
主要方法:
- 一个准实验性的前后研究设计.
- 包括接受全身抗真菌药物的353名住院患者.
- 在干预之前和之后,分析了1154个抗真菌处方.
主要成果:
- 转向增加抗真菌预防和减少治疗用途.
- 降低了预防性安二乙的剂量和减少了沃里康纳的使用.
- 在ICU入院或住院死亡率没有显著变化;成本从治疗转移到预防.
结论:
- 结构化的抗真菌管理计划在中等收入环境中的血液病学部门是可行的和安全的.
- 该干预支持更合理的抗真菌使用,而不会对患者的治疗结果产生负面影响.
- 监管可以帮助应对有限的诊断和在资源有限的环境中抵抗的挑战.
相关概念视频
Combination Therapies and Personalized Medicine
6.2K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.2K
Venous Thrombosis III: Interprofessional Care
410
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
410
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
54
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure...
54
Antimicrobial Effectiveness
1.3K
The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
1.3K
Healthcare Associated Infections II: Preventive Measures
4.4K
Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
4.4K
Heart Failure VI: Adjunct Therapies
466
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
466


